Navigation Links
Amazing Treatment Relieves Serious Back Pain Without Dangerous Drugs, Injections or Surgery!
Date:12/14/2007

CHICAGO, Dec. 14 /PRNewswire/ -- Non-surgical, spinal decompression is probably the last back pain treatment you will ever need. And you can forget about popping toxic pills, struggling through exercise programs...and...unnecessary and risky injections and surgery...because with this amazing technology - for most people - they are a thing of the past.

Dr. Thea Flock is Chicagoland's most respected authority on relieving severe back and leg pain. Dr. Flock says, "I enable people to live longer using non-invasive techniques without the use of drugs, injections or surgery."

Dr. Flock has treated many Chicagoland residents offering them a solution to their severe low back and leg pain. Patients from Florida to California and as far away as Lima, Peru have sought out her treatment programs and have found relief.

Dr. Flock is a powerful, and educational interview. She will tell your audience:

-- Why most medications often fail

-- 8 causes of low back pain

-- The worst and best things you can do for low back pain at home

-- 6 warning signs of severe back and leg pain that everyone must know

-- How you can have diminished pain and increased function in less than

5 weeks

-- How can Dr. Flock guarantee diminished pain (No other doctor I know of

is willing to make a guarantee)

Dr. Flock has been featured in many local newspapers and publications including the M.D. News. Flock lectures to many different groups educating people on severe low back pain and the treatments available. Dr. Flock offers a free report entitled "The Severe Back, Sciatica, and Disc Pain Guide" and her website, http://www.flockspinal.com is a great educational resource to learn more about severe back pain.

Flock states, "I am thrilled to be able to provide relief to my patients who haven't responded to other treatments. Often times these ar
'/>"/>

SOURCE Flock Spinal Center, S.C.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
8. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
9. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
10. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
11. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment gre... the only one to show consistent growth during the...spitals remain in trouble, and health systems are ...rsonnel, instead of just administrators. , ...lth care employment continued growing in October d...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--...mpanyfocusedondevelopingandcommercializingnovelpai...nno,PresidentandChiefExecutiveOfficer,isscheduledt...rence,tobeheldDecember1-2,2009atTheNewYorkPalaceHo...iglieri,ChiefFinancialOfficer,willbeavailabletores...
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)..., DUBLIN,November24/PRNewswire-FirstCall/--Shire...pharmaceuticalcompany,today,announcedthatithassubm...rasealfa,thecompany,senzymereplacementtherapyindev...isthethirdmarketing,applicationforvelaglucerasealf...eUnitedStatesandCanada. , Basedonaglobalsuppl...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...., March 31 Watson Pharmaceuticals, Inc. (NYSE: ..., announced today that the United States District ...Watson,s generic version of Concerta (methylphenid...ot infringe United States Patent No. 6,919,373 (th.... The opinion, dated March 30, 2009, was issued b...
...ologics announces the filing of two important prov...h 31 Quantum Immunologics, Inc. (QI), a Florida-b... has recently filed two provisional patent applica...py. , , The company,s research is focused on the...cifically, iLRP - immature Laminin Receptor Protei...
...March 31 ArunA Biomedical, Inc., a leader in huma...today that it has been awarded a Department of Def...r utilizing its human stem cell technology. , ,...080819/CLTU003LOGO ) , , The company will furth...lular model for use in a prototype biosensor devel...
Other Biology Technology:Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 3ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security 2
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
(Date:11/23/2009)... existed for 360 million years and survived when t...hreatening to make many of them extinct, according...ogy Today . , The fungus, Batrachochytrium den...waves of amphibian extinctions in Central America ...cts over 350 amphibian species by penetrating thei...
(Date:11/23/2009)...ronmental irritants such as air pollution and ciga...lished today in the American Journal of Respirato... study, from Imperial College London and the Unive... the lungs that can trigger coughing when a person...ey suggest that their findings may ultimately lead...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3
...to resist the effects of cheap and popular antivir...tionary tale about U.S. plans to use the antiviral...ction in humans, scientists say. , Researchers an...nza strains to document where and when the virus d...called adamantanes and how far resistant strains s...
...xposed to low temperatures develop more blood vess...t more quickly, according to a new study from Karo...w to control blood vessel development in humans in...th of fat cells and their metabolism depend on oxy...egulate the amount of body fat in order, for inst...
...more efficient that exploits the inertia of a wind...d speed variation, according to research published...s . , Wind power is being touted as a clean and i...he wind is intermittent and so the power output of...smooth these power fluctuations usually involve th...
Other Biology News:Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Tilting at wind farms 2
Vybrant Apoptosis Assay Kit #7 - Hoechst 33342/YO-PRO-1/propidium iodide - 200 assays from Molecular Probes (Invitrogen)
Rat TIMP-1 ELISA Kit from R&D Systems
Human Embryonic Stem Cell Marker Antibody Panel. Contains 25 g each of anti-Alkaline Phosphatase, anti-Nanog, anti-Oct-3/4, anti-SSEA-1, and anti-SSEA-4. from R&D Systems
HSV 1 IgG ELISA Kit from Biomeda Corporation
Biology Products: